SYNGENE Syngene International Limited
Healthcare
LTP
402.6
CHG · %
+4.3 (+1.08%)
VOL · TODAY
16.50L
PREV CLOSE
398.3
Today's range392.45 · 409.95
402.6
52-week range344.45 · 678.95
402.6
Loading candles…
Syngene International Ltd., established in 1993 as a subsidiary of Biocon, operates as an integrated contract research, development, and manufacturing organization. It provides end-to-end drug discovery, development, and manufacturing services (CRAMS) on a single platform. The company caters to multiple industries including pharmaceuticals, biotechnology, nutrition, animal health, consumer goods, and specialty chemicals. Syngene offers a range of services such as drug discovery and development services, manufacturing services, and scientific services spanning the entire drug discovery and development value chain. Notably, it is recognized as India's first Contract Research Organization (CRO). The company supports global pharmaceutical and biotechnology firms as a strategic partner. Its research and manufacturing facilities cover approximately 1.9 million square feet and employ a workforce of over 5,600 scientists.
SYNGENE is not part of any active scan today.
This page is a live market overview for Syngene International Limited (SYNGENE) on the BSE. As a listed security, Syngene International Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SYNGENE before placing trades on tick2trade.
As of the latest feed, SYNGENE last traded at ₹402.6 on BSE, up ₹4.3 (1.08%) from the previous close of ₹398.3. Today's session range is ₹392.45 – ₹409.95, against a 52-week band of ₹344.45 – ₹678.95. Traded volume today stands at 16.50L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SYNGENE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SYNGENE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Syngene International Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SYNGENE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SYNGENE option chain page linked from this overview.
// similar in healthcare326 total